The multidrug resistance-associated protein gene confers drug resistance in human gastric and colon cancers

Michio Tomonaga, Mikio Oka, Fumihiko Narasaki, Minoru Fukuda, Reiji Nakano, Hiroshi Takatani, Koki Ikeda, Kenji Terashi, Isao Matsuo, Hiroshi Soda, Kenneth H. Cowan, Shigeru Kohno

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

To determine the expression of multidrug resistance-associated protein (MRP) gene and its role in gastric and colon cancers, we analyzed 10 gastric and 10 colon non-drug-selected cell lines and a similar number of tissue samples of these cancers. We compared the expression of MRP and mdr1 mRNA in cell lines and tissues using reverse-transcriptase polymerase chain reaction. In mdr1-negative cells, the relationship between the level of MRP gene expression and sensitivity to anticancer drugs was examined. The effect of verapamil, an MRP-modulating agent, was also examined in these cells. The expression of MRP gene in gastric cancer cell lines varied from a low to a high level, but mdr1 was not detected in any of these cell lines. Colon cancer cell lines expressed low to intermediate levels of MRP gene, and half of the cells co-expressed low to high levels of mdr1. In tissue samples, the expression pattern of the two multidrug resistance (MDR) genes was broadly similar to that described for the cell lines, except that most of the gastric cancer tissue samples did express low levels of mdr1. No significant correlation was observed between the level of MRP gene expression and sensitivity to anticancer drugs in gastric and colon cell lines. However, verapamil significantly increased the sensitivity to etoposide, doxorubicin and vincristine in cells highly expressing MRP gene. Our results indicate that MRP gene may be important in conferring MDR in gastric and colon cancer cells.

Original languageEnglish (US)
Pages (from-to)1263-1270
Number of pages8
JournalJapanese Journal of Cancer Research
Volume87
Issue number12
DOIs
StatePublished - Dec 1996

Fingerprint

Multidrug Resistance-Associated Proteins
Drug Resistance
Colonic Neoplasms
Stomach Neoplasms
Cell Line
Genes
Verapamil
Colon
MDR Genes
Gastrointestinal Agents
Gene Expression
Multiple Drug Resistance
Vincristine
Etoposide
Reverse Transcriptase Polymerase Chain Reaction
Doxorubicin
Stomach
Messenger RNA

Keywords

  • Colon cancer
  • Gastric cancer
  • MRP
  • Modulating agent
  • Multidrug resistance

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

The multidrug resistance-associated protein gene confers drug resistance in human gastric and colon cancers. / Tomonaga, Michio; Oka, Mikio; Narasaki, Fumihiko; Fukuda, Minoru; Nakano, Reiji; Takatani, Hiroshi; Ikeda, Koki; Terashi, Kenji; Matsuo, Isao; Soda, Hiroshi; Cowan, Kenneth H.; Kohno, Shigeru.

In: Japanese Journal of Cancer Research, Vol. 87, No. 12, 12.1996, p. 1263-1270.

Research output: Contribution to journalArticle

Tomonaga, M, Oka, M, Narasaki, F, Fukuda, M, Nakano, R, Takatani, H, Ikeda, K, Terashi, K, Matsuo, I, Soda, H, Cowan, KH & Kohno, S 1996, 'The multidrug resistance-associated protein gene confers drug resistance in human gastric and colon cancers', Japanese Journal of Cancer Research, vol. 87, no. 12, pp. 1263-1270. https://doi.org/10.1111/j.1349-7006.1996.tb03142.x
Tomonaga, Michio ; Oka, Mikio ; Narasaki, Fumihiko ; Fukuda, Minoru ; Nakano, Reiji ; Takatani, Hiroshi ; Ikeda, Koki ; Terashi, Kenji ; Matsuo, Isao ; Soda, Hiroshi ; Cowan, Kenneth H. ; Kohno, Shigeru. / The multidrug resistance-associated protein gene confers drug resistance in human gastric and colon cancers. In: Japanese Journal of Cancer Research. 1996 ; Vol. 87, No. 12. pp. 1263-1270.
@article{89bfc4f0e23d4186a107431e4d110848,
title = "The multidrug resistance-associated protein gene confers drug resistance in human gastric and colon cancers",
abstract = "To determine the expression of multidrug resistance-associated protein (MRP) gene and its role in gastric and colon cancers, we analyzed 10 gastric and 10 colon non-drug-selected cell lines and a similar number of tissue samples of these cancers. We compared the expression of MRP and mdr1 mRNA in cell lines and tissues using reverse-transcriptase polymerase chain reaction. In mdr1-negative cells, the relationship between the level of MRP gene expression and sensitivity to anticancer drugs was examined. The effect of verapamil, an MRP-modulating agent, was also examined in these cells. The expression of MRP gene in gastric cancer cell lines varied from a low to a high level, but mdr1 was not detected in any of these cell lines. Colon cancer cell lines expressed low to intermediate levels of MRP gene, and half of the cells co-expressed low to high levels of mdr1. In tissue samples, the expression pattern of the two multidrug resistance (MDR) genes was broadly similar to that described for the cell lines, except that most of the gastric cancer tissue samples did express low levels of mdr1. No significant correlation was observed between the level of MRP gene expression and sensitivity to anticancer drugs in gastric and colon cell lines. However, verapamil significantly increased the sensitivity to etoposide, doxorubicin and vincristine in cells highly expressing MRP gene. Our results indicate that MRP gene may be important in conferring MDR in gastric and colon cancer cells.",
keywords = "Colon cancer, Gastric cancer, MRP, Modulating agent, Multidrug resistance",
author = "Michio Tomonaga and Mikio Oka and Fumihiko Narasaki and Minoru Fukuda and Reiji Nakano and Hiroshi Takatani and Koki Ikeda and Kenji Terashi and Isao Matsuo and Hiroshi Soda and Cowan, {Kenneth H.} and Shigeru Kohno",
year = "1996",
month = "12",
doi = "10.1111/j.1349-7006.1996.tb03142.x",
language = "English (US)",
volume = "87",
pages = "1263--1270",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - The multidrug resistance-associated protein gene confers drug resistance in human gastric and colon cancers

AU - Tomonaga, Michio

AU - Oka, Mikio

AU - Narasaki, Fumihiko

AU - Fukuda, Minoru

AU - Nakano, Reiji

AU - Takatani, Hiroshi

AU - Ikeda, Koki

AU - Terashi, Kenji

AU - Matsuo, Isao

AU - Soda, Hiroshi

AU - Cowan, Kenneth H.

AU - Kohno, Shigeru

PY - 1996/12

Y1 - 1996/12

N2 - To determine the expression of multidrug resistance-associated protein (MRP) gene and its role in gastric and colon cancers, we analyzed 10 gastric and 10 colon non-drug-selected cell lines and a similar number of tissue samples of these cancers. We compared the expression of MRP and mdr1 mRNA in cell lines and tissues using reverse-transcriptase polymerase chain reaction. In mdr1-negative cells, the relationship between the level of MRP gene expression and sensitivity to anticancer drugs was examined. The effect of verapamil, an MRP-modulating agent, was also examined in these cells. The expression of MRP gene in gastric cancer cell lines varied from a low to a high level, but mdr1 was not detected in any of these cell lines. Colon cancer cell lines expressed low to intermediate levels of MRP gene, and half of the cells co-expressed low to high levels of mdr1. In tissue samples, the expression pattern of the two multidrug resistance (MDR) genes was broadly similar to that described for the cell lines, except that most of the gastric cancer tissue samples did express low levels of mdr1. No significant correlation was observed between the level of MRP gene expression and sensitivity to anticancer drugs in gastric and colon cell lines. However, verapamil significantly increased the sensitivity to etoposide, doxorubicin and vincristine in cells highly expressing MRP gene. Our results indicate that MRP gene may be important in conferring MDR in gastric and colon cancer cells.

AB - To determine the expression of multidrug resistance-associated protein (MRP) gene and its role in gastric and colon cancers, we analyzed 10 gastric and 10 colon non-drug-selected cell lines and a similar number of tissue samples of these cancers. We compared the expression of MRP and mdr1 mRNA in cell lines and tissues using reverse-transcriptase polymerase chain reaction. In mdr1-negative cells, the relationship between the level of MRP gene expression and sensitivity to anticancer drugs was examined. The effect of verapamil, an MRP-modulating agent, was also examined in these cells. The expression of MRP gene in gastric cancer cell lines varied from a low to a high level, but mdr1 was not detected in any of these cell lines. Colon cancer cell lines expressed low to intermediate levels of MRP gene, and half of the cells co-expressed low to high levels of mdr1. In tissue samples, the expression pattern of the two multidrug resistance (MDR) genes was broadly similar to that described for the cell lines, except that most of the gastric cancer tissue samples did express low levels of mdr1. No significant correlation was observed between the level of MRP gene expression and sensitivity to anticancer drugs in gastric and colon cell lines. However, verapamil significantly increased the sensitivity to etoposide, doxorubicin and vincristine in cells highly expressing MRP gene. Our results indicate that MRP gene may be important in conferring MDR in gastric and colon cancer cells.

KW - Colon cancer

KW - Gastric cancer

KW - MRP

KW - Modulating agent

KW - Multidrug resistance

UR - http://www.scopus.com/inward/record.url?scp=12644262383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12644262383&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.1996.tb03142.x

DO - 10.1111/j.1349-7006.1996.tb03142.x

M3 - Article

C2 - 9045962

AN - SCOPUS:12644262383

VL - 87

SP - 1263

EP - 1270

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 12

ER -